Use of CFU-GM assay for prediction of human maximum tolerated dose of a new antitumoral drug: Yondelis (ET-743).
about
Novel Marine Compounds: Anticancer or Genotoxic?Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines.Two-stage model-based clinical trial design to optimize phase I development of novel anticancer agents.Two-stage model-based design of cancer phase I dose escalation trials: evaluation using the phase I program of barasertib (AZD1152).Compound-Specific Toxicities Detected in CFU-GM, Rat Kidney NRK Cells, Rat Bladder RBLAK Cells, and Rat Liver Slices following Batracylin or N-Acetyl Batracylin Exposure
P2860
Use of CFU-GM assay for prediction of human maximum tolerated dose of a new antitumoral drug: Yondelis (ET-743).
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Use of CFU-GM assay for predic ...... moral drug: Yondelis (ET-743).
@en
type
label
Use of CFU-GM assay for predic ...... moral drug: Yondelis (ET-743).
@en
prefLabel
Use of CFU-GM assay for predic ...... moral drug: Yondelis (ET-743).
@en
P2093
P1433
P1476
Use of CFU-GM assay for predic ...... umoral drug: Yondelis (ET-743)
@en
P2093
Beatriz Albella
Glynn Faircloth
Susana G Gómez
P304
P356
10.1016/S0887-2333(03)00139-5
P50
P577
2003-10-01T00:00:00Z